BaseLaunch works to attract and accelerate promising and groundbreaking healthcare startups. The project was launched in 2017 as an initiative of BaselArea.swiss. In order to tap into the unexplored potential of life sciences innovation, BaseLaunch offers a healthcare-specific accelerator program in Basel. BaseLaunch is supported by healthcare partners Novartis Venture Fund, Johnson & Johnson Innovation, Pfizer, Roche and Roivant as well as other public and private partners.
Four strong pillars help put the participating teams on the fast track to success: access to founder-friendly venture grants, insights, industry access and state-of-the-art infrastructure. Successful applicants to BaseLaunch will have free access to fully equipped laboratories at the Switzerland Innovation Park Basel Area, receive expertise from our Entrepreneurs-in-Residence, Advisors and Consultants and gain the chance to become fully embedded in one of the leading life sciences ecosystems. During phase I, financial support through BaseLaunch can be as high as 10,000 Swiss francs per project. For projects that reach phase II, up to CHF 250,000 in equity-free funding is available.
Applications are vetted by a selection committee consisting of Dr.Julian Bertschinger, VP, Head Therapeutic Platform Innovation at Janssen R&D and Managing Director of Covagen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, Dr. Phillipe Dro, CEO, NeMoDevices, Trudi Haemmerli, CEO and Director, PerioC Ltd, Managing Director, TruStep Consulting GmbH, Dr. Anja König, Managing Director, Novartis Venture Fund, Dr. Alex Mayweg, Venture Partner, Versant Ventures and Dr. Nathalie ter Wengel MD, European Head External R&D and Innovation, Pfizer.
Deadline for applications: May 14, 2018. The 15-month program starts in September 2018 and runs in two phases through December 2019. For more information watch the video below and visit: www.baselaunch.ch